Big Pharma At Crossroads After GSK Payment Reforms

Big Pharma At Crossroads After GSK Payment Reforms

Faced with a flood of False Claims Act and bribery allegations, drugmakers will be forced to take a hard look at their compensation practices after GlaxoSmithKline PLC this week took the revolutionary steps of sharply limiting payments to doctors and ...read more

  • Tags: